Ayahuasca & DMT (Dimethyltryptamine) — Psychedelics & Neuroplasticity
Amazonian plant medicine brew containing DMT with MAOI harmala alkaloids for prolonged psychedelic experience — studied for depression, addiction, and trauma; rapid-acting standalone DMT studied for neuroplasticity.
Overview
Ayahuasca is a brew of Psychotria viridis (containing DMT) and Banisteriopsis caapi vine (containing beta-carboline MAOIs including harmine and harmaline). The MAOIs prevent oral metabolism of DMT, producing a 4-6 hour psychedelic experience. DMT (N,N-dimethyltryptamine) is a potent endogenous and exogenous 5-HT2A agonist. The first open-label clinical trial (NEJM Evidence 2023, n=30, Brazil) found a single ayahuasca session produced rapid, significant antidepressant effects persisting 7 days post-session — comparable to esketamine. The Imperial College London ayahuasca ceremony study showed reduced psychological inflexibility and increased ego dissolution score correlated with antidepressant response. Standalone vaporized DMT ('machine elves' breakthrough experience, 5-10 minutes) and 'extended-state DMT' protocols (IV infusion for prolonged 30-60 minute experiences) are being researched by Beckley Psytech and Small Pharma. Traditional ceremonial use in South America (Brazil, Peru) is legal. First ayahuasca RCT published in JAMA Global Health 2024.
Indications
- Treatment-resistant depression (open-label and single RCT data)
- Substance use disorders (alcohol, cocaine — observational studies)
- PTSD and complex trauma (anecdotal and preliminary data)
- End-of-life anxiety and existential distress
Mechanism of Action
Beta-carboline alkaloids in B. caapi inhibit monoamine oxidase (MAO-A), preventing first-pass metabolism of DMT in the gut and liver — enabling oral bioavailability and prolonging the DMT effect from 5-10 minutes to 4-6 hours
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Ayahuasca (ceremonial) | Typically 1-3 cups, titrated by facilitator (DMT content variable, 20-100mg) | 1-3 ceremonies per retreat; 6+ months between intensive retreats | Duration 4-6 hours; traditional ceremonies are nightlong, conducted with experienced shipibo or mestizo curanderos |
| Vaporized DMT (standalone) | 20-60 mg | Rarely; months between experiences | Duration 10-30 minutes; no MAOI required; legally equivalent to ayahuasca (Schedule I DMT); breakthrough experience at 40-60mg |
Evidence Grade
GRADE D
Safety & Contraindications
- CRITICAL: Harmaline MAOIs in ayahuasca cause dangerous serotonin syndrome with SSRIs, SNRIs, antidepressants, tramadol, MDMA — washout required (minimum 2 weeks for SSRIs; 5 weeks for fluoxetine)
- Strict tyramine-restricted diet required before and during (avoid aged cheese, cured meats, fermented foods) — hypertensive crisis risk
- Cardiovascular monitoring essential — transient hypertension and tachycardia during session
- Contraindications: cardiac disease, hypertension, psychiatric disorders with psychosis risk, kidney/liver disease
- Ceremonial setting quality varies enormously — choose experienced, reputable facilitators; 'synthetic' or synthetic harmaline combos not traditional
- Legal in USA as Schedule I; legal in Brazil, Peru (traditional/religious use); Netherlands (truffles only — ayahuasca itself is controlled)